# Study of CM326 Injection in Healthy Subjects

> **NCT05715333** · PHASE1 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 46 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** CM326
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05715333
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-21
- **Primary completion:** 2023-10-04
- **Final completion:** 2023-10-04
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05715333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05715333, "Study of CM326 Injection in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05715333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*